TRIL
Trillium Therapeutics Inc.
TRIL
TRIL
Delisted
TRIL was delisted on the 16th of November, 2021.
84 hedge funds and large institutions have $455M invested in Trillium Therapeutics Inc. in 2020 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 24 increasing their positions, 21 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
29% more funds holding
Funds holding: 65 → 84 (+19)
14% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 21
Holders
84
Holding in Top 10
3
Calls
$9.19M
Puts
$3.35M
Top Buyers
| 1 | +$20.6M | |
| 2 | +$6.92M | |
| 3 | +$5.66M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$4.14M |
| 5 |
O
OrbiMed
New York
|
+$3.32M |
Top Sellers
| 1 | -$20M | |
| 2 | -$9.55M | |
| 3 | -$8.86M | |
| 4 |
VC
Vivo Capital
Palo Alto,
California
|
-$8.3M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$6.84M |